Ganesh Manoharan

Showing 1-8 of 8 articles

Thirty-day clinical outcomes of the Evolut PRO self-expanding transcatheter aortic valve: the international FORWARD PRO study

Manoharan G, Grube E, Van Mieghem N, Brecker S, Fiorina C, Kornowski R, Danenberg H, Ruge H, Thiele H, Lancellotti P, Søndergaard L, Tamburino C, Oh J, Fan Y, Windecker S

November 20, 2020 | 10.4244/EIJ-D-20-00279

Interventions for valvular disease

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman D, Tchétché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem N, Feldman T, Allocco D, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Coronary interventions

Comparison of clinical outcomes after multivessel versus single-vessel stenting with the zotarolimus-eluting stent in the RESOLUTE Global Clinical Trial Program

Manoharan G, Belardi J, Du Z, Lee M, Qiao S, Serruys P, Windecker S, Xu B, Yeung A

January 20, 2017 | 10.4244/EIJ-D-16-00079

Interventions for valvular disease

TAVI with current CE-marked devices: strategies for optimal sizing and valve delivery

van Gils L, Tchétché D, Latib A, Sgroi C, Manoharan G, Möllmann H, Van Mieghem N

September 18, 2016 | 10.4244/EIJV12SYA6

Interventions for valvular disease

Multicentre clinical study evaluating a novel resheathable annular functioning self-expanding transcatheter aortic valve system: safety and performance results at 30 days with the Portico system

Manoharan G, Linke A, Möllmann H, Redwood S, Frerker C, Kovac J, Walther T

August 20, 2016 | 10.4244/EIJV12I6A125

First-in-man Portico® transcatheter aortic valve-in-valve implantation in a degenerated 19 mm Mitroflow® aortic pericardial heart valve

Jeger R, Manoharan G, Kaiser C

March 20, 2014 | 10.4244/EIJV9I11A229

St Jude Medical Portico valve

Manoharan G, Spence M, Rodés-Cabau J, Webb J

September 30, 2012 | 10.4244/EIJV8SQA18

Complications of transcatheter aortic valve implantation: avoidance and management

Hildick-Smith D, Redwood S, Mullen M, Thomas M, Kovac J, Brecker S, Trivedi U, Young C, Hutchinson N, MacCarthy P, Prendergast B, De Belder M, Monaghan M, Blackman D, Baumbach A, Manoharan G, Moat N

September 30, 2011 | 10.4244/EIJV7I5A99

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

The Year in Review

M. Lunardi et al.

January 22, 2021

Valvular disease